GLUE
Price
$17.56
Change
-$0.18 (-1.01%)
Updated
Jun 3, 04:59 PM (EDT)
Capitalization
1.66B
64 days until earnings call
Intraday BUY SELL Signals
KURA
Price
$8.66
Change
-$0.31 (-3.46%)
Updated
Jun 3, 04:59 PM (EDT)
Capitalization
796.31M
57 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GLUE vs KURA

Header iconGLUE vs KURA Comparison
Open Charts GLUE vs KURABanner chart's image
GLUE vs KURA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
GLUE vs. KURA commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLUE is a Hold and KURA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 03, 2026
Stock price -- (GLUE: $17.74 vs. KURA: $8.97)
Brand notoriety: GLUE and KURA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GLUE: 110% vs. KURA: 160%
Market capitalization -- GLUE: $1.66B vs. KURA: $796.31M
GLUE [@Biotechnology] is valued at $1.66B. KURA’s [@Biotechnology] market capitalization is $796.31M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.89B to $0. The average market capitalization across the [@Biotechnology] industry is $1.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLUE’s FA Score shows that 1 FA rating(s) are green whileKURA’s FA Score has 0 green FA rating(s).

  • GLUE’s FA Score: 1 green, 4 red.
  • KURA’s FA Score: 0 green, 5 red.
According to our system of comparison, both GLUE and KURA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLUE’s TA Score shows that 1 TA indicator(s) are bullish while KURA’s TA Score has 3 bullish TA indicator(s).

  • GLUE’s TA Score: 1 bullish, 6 bearish.
  • KURA’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, KURA is a better buy in the short-term than GLUE.

Price Growth

GLUE (@Biotechnology) experienced а -7.60% price change this week, while KURA (@Biotechnology) price change was -13.83% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.54%. For the same industry, the average monthly price growth was -1.96%, and the average quarterly price growth was +3.26%.

Reported Earning Dates

GLUE is expected to report earnings on Aug 06, 2026.

KURA is expected to report earnings on Jul 30, 2026.

Industries' Descriptions

@Biotechnology (-1.54% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GLUE($1.66B) has a higher market cap than KURA($796M). GLUE YTD gains are higher at: 13.138 vs. KURA (-13.667). GLUE has higher annual earnings (EBITDA): -139.94M vs. KURA (-212.24M). GLUE has more cash in the bank: 666M vs. KURA (550M). KURA has less debt than GLUE: KURA (19.5M) vs GLUE (39.1M). KURA has higher revenues than GLUE: KURA (104M) vs GLUE (43M).
GLUEKURAGLUE / KURA
Capitalization1.66B796M209%
EBITDA-139.94M-212.24M66%
Gain YTD13.138-13.667-96%
P/E Ratio49.25N/A-
Revenue43M104M41%
Total Cash666M550M121%
Total Debt39.1M19.5M201%
FUNDAMENTALS RATINGS
KURA: Fundamental Ratings
KURA
OUTLOOK RATING
1..100
81
VALUATION
overvalued / fair valued / undervalued
1..100
48
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GLUEKURA
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 6 days ago
88%
Bullish Trend 13 days ago
79%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
82%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
85%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
GLUE
Daily Signal:
Gain/Loss:
KURA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SIFZX28.130.25
+0.90%
Saturna International Z
MDDLX9.29N/A
N/A
MassMutual Diversified Value Adm
VWNFX50.42N/A
N/A
Vanguard Windsor II Inv
MFWLX17.92N/A
N/A
MFS Global Total Return R6
RGDTX12.27N/A
N/A
Russell Inv Global Equity M

GLUE and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLUE has been loosely correlated with CRNX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if GLUE jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLUE
1D Price
Change %
GLUE100%
-9.81%
CRNX - GLUE
42%
Loosely correlated
-5.59%
KURA - GLUE
39%
Loosely correlated
-0.72%
AXON - GLUE
38%
Loosely correlated
+2.78%
XNCR - GLUE
37%
Loosely correlated
-5.00%
IMNM - GLUE
37%
Loosely correlated
-7.03%
More